BLIS - Breastfeeding Levonorgestrel IUD Study

Launched by UNIVERSITY OF UTAH · Nov 15, 2013

Keywords

ClinConnect Summary

Increasing use of the levonorgestrel intrauterine device (LNG IUD) has become a cornerstone of U.S. efforts to decrease our nation's high rate of unplanned pregnancy. Many women initiate use of this method in the post partum period. The major advantage of immediate postplacental LNG IUD insertion is the prompt initiation of a highly effective contraceptive method at a time that does not interfere with the intense demands of newborn care, but any contraceptive method initiated in the postpartum period must not interfere with breastfeeding.

Our long-term goal is to understand the impact of h...

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Healthy, 18-40 year old pregnant women
• • Intend to breastfeed
• • Desire the LNG IUD as their method of contraception
• • Agree to be randomized to early versus standard postpartum insertion
• • Have delivered a healthy term infant (37 weeks gestation)
• • Willing to complete all study related procedures, visits and questionnaires
• Exclusion Criteria:
• • Chorioamnionitis
• • Obstetric complications including transfusion
• • Severe pregnancy induced hypertension
• • Prolonged hospitalization
• • Coagulopathy
• • Liver disease
• • Undiagnosed genital bleeding, or other relative contraindication to LNG IUD insertion (known or suspected pregnancy, uterine cavity abnormality, known, suspected, or history of breast cancer, or hypersensitivity to any of the components in the LNG IUD).